[EU] CPR Ingredient Annex Amendments Due
These entries are based on Regulation 2024/996 and are due to come into force soon;
Annex II
- The UV filter4-methylbenzylidene camphor is added to Annex II and therefore banned from use in cosmetic products. The placing on the market deadline was May 1, 2025 and the making available (off-shelf) deadline is May 1, 2026.
Annex III
- Retinol, retinyl acetate, retinyl palmitate restricted in body lotions to a maximum concentration of retinol equivalent (RE) of 0.05% and other leave-on and rinse-off products to a maximum concentration of RE of 0.3%.
Cosmetics with Retinol, retinyl acetate, retinyl palmitate must be labelled with the warning: “Contains Vitamin A. Consider your daily intake before use.”
The deadline for placing on the market is Nov. 1, 2025 and the making available (off-shelf) deadline is May 1, 2027.
- Genistein restriction in cosmetic products at a maximum concentration of 0.007%. The deadline for placing on the market was Feb. 1, 2025; the making available (off-shelf) deadline is Nov. 1, 2025.
- Daidzein can be used in cosmetic products at a maximum concentration of 0.02%. The deadline for placing on the market was Feb. 1, 2025, while the making available (off shelf) deadline is Nov. 1, 2025.
- Kojic acid is allowed in face and hand cosmetic products at a maximum concentration of 1%. The deadline for placing on the market was Feb. 1, 2025 and the making available (off-shelf) deadline is Nov. 1, 2025.
- Alpha arbutin allowed to be used in face cream at a maximum concentration of 2%, and body lotion at a maximum concentration of 0.5%.
Additionally, hydroquinone levels shall remain as low as possible in formulations containing alpha-arbutin and shall not be higher than the unavoidable trace level.
The deadline for placing on the market was Feb. 1, 2025, and the making available (off-shelf) deadline is Nov. 1, 2025.
- Arbutin can be used in face cream at a maximum concentration of 7%. Hydroquinone levels must remain as low as possible in formulations containing arbutin and must not be higher than the unavoidable trace level. The deadline for placing on the market was Feb. 1, 2025. The making available (off-shelf) deadline is Nov. 1, 2025.
Annex V
- Triclocarban can be used in all cosmetic products except for mouthwash at a maximum concentration of 0.2%. Purity criteria include the presence of 3,3′,4,4′-tetrachloroazobenzene at ≤ 1 ppm and 3,3′,4,4′-tetrachloroazoxybenzene at ≤ 1 ppm.
Triclocarban cannot to be used in toothpaste intended for children under six years of age. Therefore, toothpaste containing triclocarban must have the following warning: “Not to be used for children under 6 years of age.”
- Triclosan can be used in toothpastes, hand soaps, body soaps/shower gels, deodorants (non-spray), face powders and blemish concealers, products for cleaning the fingernails and toenails before the application of artificial nail systems at a maximum concentration of 0.3%.
Triclosan cannot to be used in toothpaste intended for children under three years of age. Therefore, toothpaste containing triclocarban must have the following warning: “Not to be used for children under three years of age.”
The deadline for placing on the market for both ingredients was Dec. 31, 2024, and the making available (off-shelf) deadline is Oct. 31, 2025.
Need help navigating these changes?
Reach out to our regulatory experts for tailored guidance and support in adapting to the new requirements.
Subscribe to our newsletter to stay informed on future amendments and industry insights.